REAX (REAX)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8% | 10% | 12% |
|---|---|---|---|
| 2% | $13 | $9 | $7 |
| 3% | $15 | $11 | $8 |
| 4% | $18 | $12 | $9 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $11 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in REAX to visualize passive redemption contagion across ETFs and collateral stocks.
If REAX (REAX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies MEIKO ELECTRONICS CO LTD (6787) as the most exposed collateral stock, sharing 1 ETFs with REAX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
REAX Ownership Dynamics
ETFs with Highest REAX Exposure
Float lock-up computed from 1 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 1,700 | $1.75 | $2,975 |
| 2026-05-13 | 193,466 | $1.86 | $359,846.76 |
| 2026-05-07 | 412,750 | $2.09 | $862,647.5 |
| 2026-05-04 | 69,781 | $2.13 | $148,633.53 |
| 2026-05-01 | 147,874 | $2.10 | $310,535.4 |
| 2026-04-30 | 210,978 | $2.15 | $453,602.7 |
| 2026-04-29 | 217,107 | $2.22 | $481,977.54 |
| 2026-04-28 | 225,499 | $2.02 | $455,507.98 |
| 2026-04-21 | 1,201 | $2.72 | $3,266.72 |
| 2026-04-14 | 17,093 | $2.56 | $43,758.08 |
| 2026-04-10 | 2,542 | $2.49 | $6,329.58 |
| 2026-03-31 | 543 | $2.41 | $1,308.63 |
| 2026-03-12 | 86 | $2.40 | $206.4 |
| 2026-03-11 | 4,376 | $2.45 | $10,721.2 |
| 2026-03-10 | 3,921 | $2.52 | $9,880.92 |
| 2026-03-06 | 254,162 | $2.60 | $660,821.2 |
| 2026-03-02 | 220 | $2.65 | $583 |
| 2026-02-26 | 2,895 | $2.73 | $7,903.35 |
| 2026-02-25 | 10,000 | $2.59 | $25,900 |
| 2026-02-19 | 155 | $2.58 | $399.9 |
| 2026-02-18 | 518 | $2.63 | $1,362.34 |
| 2026-02-13 | 10,000 | $2.65 | $26,500 |
| 2026-02-12 | 3,321 | $2.88 | $9,564.48 |
| 2026-02-11 | 3,171 | $3.14 | $9,956.94 |
| 2026-01-26 | 134 | $3.68 | $493.12 |
| 2026-01-21 | 956 | $3.57 | $3,412.92 |
| 2026-01-14 | 678 | $4.08 | $2,766.24 |
| 2026-01-13 | 137 | $4.27 | $584.99 |
| 2025-12-23 | 7,532 | $3.99 | $30,052.68 |
| 2025-12-12 | 42,561 | $4.27 | $181,735.47 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare REAX to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.